Structure and dynamics of the CGRP receptor in apo and peptide-bound forms.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
09 04 2021
Historique:
received: 15 11 2020
accepted: 11 02 2021
pubmed: 20 2 2021
medline: 28 4 2021
entrez: 19 2 2021
Statut: ppublish

Résumé

G protein-coupled receptors (GPCRs) are key regulators of information transmission between cells and organs. Despite this, we have only a limited understanding of the behavior of GPCRs in the apo state and the conformational changes upon agonist binding that lead to G protein recruitment and activation. We expressed and purified unmodified apo and peptide-bound calcitonin gene-related peptide (CGRP) receptors from insect cells to determine their cryo-electron microscopy (cryo-EM) structures, and we complemented these with analysis of protein conformational dynamics using hydrogen-deuterium exchange mass spectrometry and three-dimensional variance analysis of the cryo-EM data. Together with our previously published structure of the active, Gs-bound CGRP receptor complex, our work provides insight into the mechanisms of class B1 GPCR activation.

Identifiants

pubmed: 33602864
pii: science.abf7258
doi: 10.1126/science.abf7258
pii:
doi:

Substances chimiques

Apoproteins 0
CALCRL protein, human 0
Calcitonin Receptor-Like Protein 0
Ligands 0
RAMP1 protein, human 0
Receptor Activity-Modifying Protein 1 0
Receptors, Calcitonin Gene-Related Peptide 0
GTP-Binding Protein alpha Subunits, Gs EC 3.6.5.1
Calcitonin Gene-Related Peptide JHB2QIZ69Z

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Tracy M Josephs (TM)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.

Matthew J Belousoff (MJ)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.

Yi-Lynn Liang (YL)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.

Sarah J Piper (SJ)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.

Jianjun Cao (J)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.

Daniel J Garama (DJ)

Hudson Institute of Medical Research, Clayton 3168, Victoria, Australia.
Department of Molecular and Translational Science, Monash University, Clayton 3168, Victoria, Australia.

Katie Leach (K)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.

Karen J Gregory (KJ)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.

Arthur Christopoulos (A)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.

Debbie L Hay (DL)

Department of Pharmacology and Toxicology, University of Otago, Dunedin 9054, New Zealand.

Radostin Danev (R)

Graduate School of Medicine, University of Tokyo, N415, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan. rado@m.u-tokyo.ac.jp denise.wootten@monash.edu patrick.sexton@monash.edu.

Denise Wootten (D)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia. rado@m.u-tokyo.ac.jp denise.wootten@monash.edu patrick.sexton@monash.edu.

Patrick M Sexton (PM)

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia. rado@m.u-tokyo.ac.jp denise.wootten@monash.edu patrick.sexton@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH